V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20129019 | 20157821 | 1.57 | 65 | null | 2016-07-12 | 2016-08-01 | Fluorouracil + Folinic + RT Bossett | 01 | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 101536188 |
| 20129056 | 20157822 | 1.8 | 61.2 | Curative (C) | 2020-11-09 | 2020-12-13 | Cisplatin + Docetaxel | null | null | TRABECTEDIN | 100477129 |
| 20129164 | 20157824 | 1.65 | 60 | null | 2019-10-16 | 2020-01-03 | CAPECITABINE + IRINOTECAN + Panitumumab | 02 | null | CISPLATIN + TEYSUNO | 101311392 |
| 20129205 | 20157825 | 1.61 | 67.1 | Palliative (P) | 2017-05-06 | 2017-05-29 | ACTICCA-1 Trial | 02 | null | CAP + RT | 100994138 |
| 20129223 | 20157826 | 1.85 | 56 | Palliative (P) | 2017-12-06 | 2017-12-12 | Cape+Cetuximab+Oxalip (2 wk) Maint | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100465742 |
| 20129467 | 20157827 | 1.8 | 118.5 | Palliative (P) | null | 2019-02-26 | FOXTROT TRIAL | 2 | N | CAPECITABINE + CETUXIMAB + OXALIPATIN | 100197399 |
| 20129620 | 20157828 | 1.95 | 64.3 | Neo-adjuvant (N) | 2018-10-01 | 2019-02-19 | CAP + RT | N | N | CARBOPLATIN + DOCETAXEL | 101556988 |
| 20129917 | 20157830 | null | null | Palliative (P) | 2019-03-05 | 2019-03-15 | Gemcitabine + Oxaliplatin | 02 | Y | GDP | 101225247 |
| 20130142 | 20157831 | 1.72 | 91.08 | null | null | 2018-12-17 | ICE-R | 2 | N | CAPECITABINE + LOMUSTINE | 101542528 |
| 20130428 | 20157832 | 1.87 | 72.7 | null | 2019-02-22 | 2019-10-20 | Cisplatin + Radiotherapy | Y | N | HYDROXYCARBAMIDE | 100859039 |
| 20130468 | 20157833 | 1.61 | 59.6 | null | 2016-10-31 | 2017-03-03 | PHITT D SIOPEL-4 (A1, A2, A3) | 02 | null | CYCLO + DOXORUBICIN + VINCRISTINE | 101289378 |
| 20130606 | 20157834 | 1.47 | 83.85 | Palliative (P) | 2017-08-25 | 2017-08-26 | EW EuroEwing 2012 Arm B IE | 02 | N | IXAZOMIB + LENALIDOMIDE | 101804728 |
| 20130639 | 20157835 | 1.82 | 73.4 | null | 2018-12-27 | 2019-01-27 | SCOPE 2 TRIAL | 02 | null | GEMCITABINE + PACLITAXEL | 100312151 |
| 20130640 | 20157836 | 1.77 | 69 | Palliative (P) | 2016-01-05 | 2017-05-25 | Alectinib | 02 | N | BEVACIZUMAB + FLUOROURACIL + IRINOTECAN | 101565384 |
| 20130723 | 20157837 | 1.6 | 66.85 | Neo-adjuvant (N) | 2016-11-21 | 2017-12-05 | TCH (21 day Trastuzumab) Loading | 02 | N | CAP + RT | 101603228 |
| 20130762 | 20157838 | 1.61 | 61.4 | Curative (C) | 2017-02-24 | 2017-02-25 | null | 02 | N | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 100789923 |
| 20130859 | 20157839 | 1.69 | null | null | 2021-09-25 | 2021-12-17 | Azacitidine | 02 | N | RITUXIMAB | 100969867 |
| 20131277 | 20157840 | 1.79 | 104.2 | 03 | 2015-08-01 | 2018-02-09 | Cabazitaxel | 02 | null | AXITINIB | 100068975 |
| 20131500 | 20157841 | 1.52 | 72.5 | 03 | 2019-04-28 | 2020-03-15 | CARFILZOMIB + LENALIDOMIDE | 02 | N | DOCETAXEL + GEMCITABINE | 100071965 |
| 20131694 | 20157842 | 1.69 | 95.5 | Curative (C) | 2020-06-22 | 2020-07-08 | Gemcitabine + RT pancreas | 02 | null | DOCETAXEL + NINTEDANIB | 101227084 |
| 20131904 | 20157844 | 1.57 | 104.9 | Palliative (P) | 2017-04-12 | 2017-08-16 | CAPE + OXALIPLATIN + TRASTUZUMAB | N | N | ABVD | 100112547 |
| 20131959 | 20157845 | 1.47 | 80 | null | 2018-12-12 | 2019-04-29 | CAV | N | Y | CISPLATIN + RT | 101090541 |
| 20132270 | 20157847 | 1.86 | 65.15 | null | 2021-08-29 | 2021-09-07 | ST03 TRIAL | 02 | N | ANAGRELIDE | 101458958 |
| 20132504 | 20157848 | 1.56 | 66.5 | Curative (C) | 2017-08-12 | 2018-02-03 | FOCUS4 TRIAL | 02 | N | BEVACIZUMAB + FLUOROURACIL + IRINOTECAN | 101336593 |
| 20132554 | 20157850 | 1.6 | 67.65 | Palliative (P) | 2019-07-10 | 2019-11-30 | Bevacizumab + Oxaliplatin +MdG | N | N | CAPECITABINE + STREPTOZOCIN | 100882584 |
| 20132615 | 20157851 | 1.73 | 71 | Palliative (P) | 2020-02-22 | 2020-09-06 | CHOP R - 21 days | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 101410148 |
| 20132689 | 20157852 | 1.8 | 98 | null | 2017-10-07 | 2018-03-27 | null | 02 | N | CYCLOPHOSPHAMIDE + LENALIDOMIDE | 100298501 |
| 20132768 | 20157853 | 1.57 | 0 | Palliative (P) | 2019-03-19 | 2019-03-19 | Bortezomib + Daratumumab | 02 | N | PEMETREXED | 100870828 |
| 20133069 | 20157854 | 1.83 | 46.8 | Palliative (P) | 2020-07-11 | 2020-07-17 | Atezolizumab | 02 | N | BORTEZOMIB + PANOBINOSTAT | 100072128 |
| 20133073 | 20157855 | 1.81 | 0 | null | 2016-06-12 | 2016-07-17 | ESPAC-4 TRIAL | 02 | Y | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100460249 |
| 20133166 | 20157856 | 1.78 | 101.4 | Palliative (P) | 2018-12-28 | 2019-03-30 | MIC | 01 | N | DABRAFENIB + TRAMETINIB | 101471080 |
| 20133496 | 20157857 | 1.2 | 78.8 | Palliative (P) | 2019-07-27 | 2019-08-03 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | ATEZOLIZUMAB | 100415174 |
| 20133526 | 20157858 | 1.75 | 0 | Neo-adjuvant (N) | 2020-08-31 | 2020-09-25 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 02 | null | RITUXIMAB | 101369305 |
| 20134283 | 20157860 | 1.79 | 68.4 | Palliative (P) | 2022-01-22 | 2022-03-26 | BCG Intravesical | 02 | null | VENETOCLAX | 101408901 |
| 20134721 | 20157862 | 1.57 | 105 | null | 2019-04-05 | 2019-04-05 | Topotecan (oral) | 02 | null | CARBOPLATIN + PEMETREXED | 100284389 |
| 20134770 | 20157863 | 1.6 | 70 | null | 2017-11-21 | 2018-09-23 | Capecitabine + Carboplatin + RT | 02 | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 101506005 |
| 20135005 | 20157865 | 0 | 83.6 | Neo-adjuvant (N) | 2021-04-21 | 2021-05-12 | ECarboX | N | null | MITOXANTRONE | 101151596 |
| 20135121 | 20157866 | 1.77 | 50.1 | Palliative (P) | 2018-06-02 | 2018-06-02 | COSMIC TRIAL | 02 | N | CAPECITABINE + IRINOTECAN + PANITUMUMAB | 101133199 |
| 20135185 | 20157867 | 1.75 | 55 | null | 2016-06-04 | 2021-08-06 | CAV | 02 | null | FLUOROURACIL + RT | 101110654 |
| 20135389 | 20157868 | null | 71 | Palliative (P) | 2022-01-20 | 2022-01-20 | Atezolizumab | 02 | N | CAV | 101563665 |
| 20135442 | 20157869 | 1.57 | 57 | Curative (C) | 2018-09-07 | 2019-05-03 | Cisplatin + Fluorouracil + RT 5day | 02 | N | DARATUMUMAB | 101724864 |
| 20135459 | 20157870 | 1.69 | 79.8 | Palliative (P) | 2019-10-19 | 2019-11-09 | IBRUTINIB | 02 | N | FOCUS4 TRIAL | 101253577 |
| 20136351 | 20157871 | 1.84 | 77.4 | null | 2019-12-05 | 2019-12-13 | Cetuximab + FLUOROURACIL | 02 | null | IBRUTINIB | 100060612 |
| 20136372 | 20157872 | 1.57 | 78.7 | Palliative (P) | 2020-05-09 | 2020-05-09 | DARATUMUMAB | 02 | N | CARBOPLATIN + RT | 100360565 |
| 20136481 | 20157873 | 1.46 | 61.95 | Palliative (P) | 2017-01-27 | 2017-01-28 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | null | IRINOTECAN + RALTITREXED | 100512315 |
| 20137001 | 20157874 | 1.48 | 81.7 | Curative (C) | 2019-01-22 | 2019-01-28 | Cytarabine Low Dose | 02 | null | IPILIMUMAB + NIVOLUMAB | 101120480 |
| 20137438 | 20157875 | 1.69 | 42.4 | null | 2020-08-31 | 2021-01-05 | MIC | 02 | N | GEMCITABINE + OXALIPLATIN | 101069527 |
| 20137533 | 20157876 | 1.56 | 57.7 | null | 2019-07-12 | 2019-08-07 | ECarboX | 01 | null | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 101488838 |
| 20138126 | 20157877 | 1.68 | 91.6 | Disease modification (D) | 2022-05-07 | 2022-05-14 | ISATUXIMAB + POMALIDOMIDE | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101600837 |
| 20138373 | 20157878 | 1.69 | null | Palliative (P) | 2017-05-24 | 2017-05-28 | null | 02 | null | ERIBULIN | 101440199 |